Eris Lifesciences Limited — Call Transcript 2025

Nov 6, 2025

==> picture [594 x 125] intentionally omitted <==

Date: 06 November 2025

To To BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers Exchange Plaza Dalal Street Bandra Kurla Complex Mumbai – 400001 Bandra (E) Mumbai – 400051 Security Code: 540596 Symbol: ERIS

SUBJECT: INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL

Dear Sir/Madam,

This is further to our letter dated November 06, 2025, intimating about the date of the Board of Directors Meeting to, inter alia, consider and approve the standalone and consolidated unaudited financial results of the Company for the quarter and half year ended September 30, 2025.

We wish to inform that pursuant to Regulation 30 and other applicable regulations, if any, of the SEBI (LODR) Regulations, 2015, the Company will hold a conference call for analysts and investors on Wednesday, November 12, 2025, at 04:30 P.M. IST. The details of the said call are attached herewith and are also available on Company’s website.

Thank you.

For Eris Lifesciences Limited

Milind Digitally signed by Milind Talegaonk Talegaonkar Date: 2025.11.06 ar 15:24:06 +05'30' _________________________ Milind Talegaonkar Company Secretary and Compliance Officer Membership No.: A26493

Encl.: a/a

==> picture [592 x 72] intentionally omitted <==

==> picture [308 x 24] intentionally omitted <==

==> picture [440 x 30] intentionally omitted <==

Day/Date: Wednesday, 12[th] November 2025 Time: 4:30 PM, IST To join the call through Zoom: Please pre-register by clicking here or copy and paste the following link in your browser https://zoom.us/webinar/register/WN_xF1hvDBLTDmUNuqVA -h92Q#/registration

We look forward to your participation Kruti Raval / Atul Modi R S V P : E: kruti.raval@erislifesciences.com E: atul.modi@eristherapeutics.com

https://eris.co.in/